Carmot Therapeutics Inc - Company Review
Carmot Therapeutics Inc - Company ReviewSummary
Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company which discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company’s product portfolio encompasses investigational candidates in preclinical trials: peptide-small molecule hybrid compounds that target Nonalcoholic Steatohepatitis (NASH), protein-protein interactions (NEMO/IKK) for the treatment of cancer and inflammation; and GLP-1R/GIPR for treating Type 2 diabetes and obesity. Carmot Therapeutics proprietary technology, Chemotype Evolution applies to identify and optimize innovative drugs for various therapeutic areas. The company works in collaboration with research institutions and companies such as Amgen Inc and Genentech for discovery of new drugs. Carmot Therapeutics is headquartered in San Francisco, California, the US.
This comprehensive company report of Carmot Therapeutics Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.